Tobacco Companies Targeting Health Professionals: Dentistry and PMI

This page was last edited on at

Dentists, like doctors, pharmacists and other health professionals, have long been targeted by tobacco companies, to help promote their products and to attempt to build trust and credibility. The tobacco industry also has a long history of attempting to influence science and medical practice, primarily in the service of their own business goals. Despite the fact that most oral cancers result from tobacco use,1 oral health is rarely considered in discussions around tobacco control policy and product regulation.2

Transnational tobacco companies have been increasingly positioning themselves as experts in this area, particularly Philip Morris International (PMI),34 as part of a broader business-focussed harm reduction strategy.

Although there have been attempts to limit and counter tobacco industry influence, some oral health practitioners continue to be co-opted in the service of commercial interests. This article highlights the tactics of tobacco companies, focussing on those used by Philip Morris International (PMI) to target the dental profession.

Background: The Tactics

Tobacco companies apply the same tactics as used towards other health professions, and to influence science more broadly. They attend conferences relating to dentistry and oral health,5 sponsoring some events;67 they conduct, commission or fund research;891011 they run training programmes;12 and have published articles in magazines aimed at oral health professionals.1213

PMI’s Strategy

PMI uses a range of tactics to target the dental profession, build relationships with organisations and practitioners, and promote its transformation narrative.14 These efforts may help to create, or expand, markets for newer nicotine and tobacco products – primarily heated tobacco products (HTPs) and specifically PMI’s flagship product IQOS.

Business objectives

A leaked 2019 internal document from Philip Morris Japan (PMJ), analysed by TCRG researchers, gives an indication of PMJ’s strategy for increasing sales of IQOS. Called “PMJ 2019 Business Objectives” it showed how, as well as targeting politicians, sports organisations and the hospitality sector, PMJ planned to build relationships with the dentistry community.3 The purpose was to gain “third-party scientific endorsement” of PMI’s approach to harm reduction in Japan – centred on the use of IQOS – which would potentially help it to secure favourable regulation in other countries.15

One activity detailed was a dentist referral programme to be piloted with “15-50” dentists in Japan.1516 For more on how tobacco companies target ‘Key Opinion Leaders’ see Tobacco Companies Targeting Health Professionals

Conducted and funded research

In September 2020, the Dental Tribune reported that PMI had presented findings from market research it commissioned in Germany in 2018, which surveyed doctors, dentists, and pharmacists. 1718 PMI stated that:

more than half of German dentists feel that they struggle to provide advice to their patients about alternative tobacco products, owing to a lack of information”.1718

The then manager of scientific and medical affairs at PMI’s German subsidiary, Dr Charilaos Avrabos, was quoted saying that the company is:

engaging with the scientific and medical community by presenting its research and findings in an open and transparent way at conferences, by making data and study results available in the form of brochures, and by meeting face to face with medical professionals to inform them about products.”17

No further details were given as to the methods of the market research, or whether participants were aware that it was being conducted on behalf of a tobacco company. Related media coverage referred to a dentist in Germany promoting the use of HTPs (although the supporting research it cited related to e-cigarettes).18

It is also unclear whether PMI was referring to the same market research it had promoted in May 2020. This contained some identical figures, and referred to “a series of surveys” which they would use to “initiate a dialogue” with healthcare professionals, but did not specifically mention dentists.19

PMI has also conducted and commissioned  research on the impact of HTPs on oral health . Papers published in 2016 and 2018 covered impacts on oral epithelial cells.2021 Other papers related to the effects of HTPs on dental composites (2017 and 2019),2223 and tooth enamel (2020).24  In 2019, PMI published an article on its website detailing its research on HTPs (referred to as ‘Tobacco Heating Systems’) and tooth colour.25 PMI also published papers in 2019 and 2020 which included the dental impacts of e-cigarettes.2627

The aforementioned studies are all non-clinical (i.e. not tested in human subjects). The time frames are also relatively short: the oral cells being exposed at most for 28 mins per day for 3 days and the dental composites/tissues tested for a maximum of 3 weeks.

From 2017 to 2019, PMI ran a clinical trial investigating the effects of IQOS on oral health and periodontitis treatment outcome in smokers.8 The protocol was published in 2021,28 and findings in 2022.29 No significant differences were found between switching to IQOS or continued smoking on oral health outcomes after 6 months. This clinical study did not measure tooth staining.30 In 2024, PMI updated the article, now on its PMI Science website, to include its research on HTPs and dental composites, stating:25

As smokers switch to heated tobacco products, it becomes important from a social and oral health perspective to develop a deeper understanding of the role these products can play in reducing tooth staining as compared with cigarettes.”

Advertised in medical and dental publications

Researchers reported in 2024 how PMI promoted HTPs to dental professionals in Japan.13 In 2018, PMI placed an advertisement in Nikkei Medical, a magazine which is widely read by health professionals including dentists. It featured comments from an oral surgeon, and implied that HTPs may help reduce periodontal disease – although at the time PMI research was still ongoing.133

In September 2021, PMI placed another advertisement for IQOS in Japan Dental News. This promoted four research studies on HTPs and oral hygiene, research which was partly funded by PMI and led by a PMI scientist.13 The researchers noted that the advertisement included quotations from dentists which were not attributed to named individuals or say whether they were paid, and it “implied that the products had been evaluated and validated in the oral health field”. According to the authors, these advertisements confirmed that:

“PMI is taking advantage of people’s trust in aesthetic dentistry professionals to promote the switch from PMI to IQOS”.13

The same month the Word Dental Federation (Fédération Dentaire Internationale, or FDI) adopted a new policy statement on the role of oral health practitioners in tobacco cessation, which stated that HTPs should not be recommended as an alternative to cigarettes or for cessation.1331

Since at least 2022, PMI has also paid for content to be placed in German magazines aimed at dental professionals.123233

Organised events for dentists

In addition to sponsoring and attending conferences relating to dentistry and oral health PMI has organised events specifically for dentists, including webinars on specialist e-learning platforms.12

PMI has run numerous webinars in Germany targeted at dentists and their practice teams.12343536

Third parties

The Foundation for a Smoke-Free World –renamed Global Action to End Smoking in 2024 – is a US based grant-giving nonprofit foundation. FSFW was solely funded by Philip Morris International (PMI) under a multi-year pledge (2018-23).37

FSFW/GAES has given grants to other third party organisations which have in turn funded work with dental and oral health professionals.

K-A-C

Knowledge-Action-Change (K-A-C) is a private organisation which receives grant funding from FSFW/GAES. In 2018 it awarded an “enhanced” scholarship to a dentistry professor for research on the effects of IQOS on oral health “in individuals from the large smoking and relatively large vaping and iQOS communities present in Romania”.38394041 This research, presented at the Global Forum on Nicotine in 2019,42 focussed solely on PMI’s brand IQOS, not HTPs more generally. The study included 20 participants who expressed an interest in quitting, and were briefed on the advantages and disadvantages of using different products, including Nicotine Replacement Therapy (NRT), snus, e-cigarettes and HTPs. The project summary stated that “Most of the patients chose to use heat-not-burn, and in particular IQOS, which is very popular in Romania.” It then stated that, apart from the 5 patients in the control group, the remainder “chose IQOS”.43 A subsequent journal paper published in 2021, did not contain any funding or conflict of interest statement.44

CoEHAR

The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), founded in 2018 by Professor Riccardo Polosa at the University of Catania in Italy, was set up with FSFW funding as one of several “centres of excellence” for research on harm reduction. The official FSFW grantee is ECLAT SRL.45

A research project lead by CoEHAR called “SMILE” states that it “aims to assess the impact of cigarette smoking and of reduced-risk products on oral health, in four different countries, Italy, Poland, Moldova and Indonesia.”4647 484950

As with previous publications, a 2024 CoEHAR paper, on the impact of HTPs and e-cigarettes on tooth colour, acknowledges FSFW funding, stating that “ [T]the authors are solely responsible for the content, selection, and presentation of facts, as well as any opinions expressed in this study. These views should not be interpreted as reflecting the positions of the Foundation for a Smoke-Free World, Inc.”.51 In this paper the authors do not include a statement on conflict of interest.51 A protocol for a clinical trial was also published in February 2024.52

A paper on impacts on dental plaque, in users of HTPs and e-cigarettes, published in August 2024, acknowledges GAES funding and contains the statement: “Global Action played no role in designing, implementing, data analysis, or interpretation of the study results. The contents, selection, and presentation of facts, as well as any opinions expressed, are the sole responsibility of the authors and should not be regarded as reflecting the positions of Global Action to End Smoking.”53 The declaration of competing interest states that Polosa has received grants from FSFW.53 In this paper the authors include HTPs in their definition of Electronic Nicotine Delivery Systems (ENDS), seemingly conflating two distinct products types, HTPs and e-cigarettes (ENDS).53 World Health Organisation guidance states that HTPs should be treated as tobacco products and regulated accordingly,54 as per the decision taken at the eighth Conference of the Parties (COP 8) to the WHO Framework Convention on Tobacco Control (WHO FCTC).5556

CoEHAR has partnered with the faculty of dentistry at a university in Indonesia, in the SMILE project, and another called REPLICA.57 There appeared to be a proposal to establish CoEHAR as a “leading centre for harm reduction in Asia” at the university.57

Relevant Links

Tobacco Tactics Resources

TCRG Research

“Let us all work together for the larger public health good.” Philip Morris targeting German dental professionals, B.K. Matthes, L. Graen, K. Schaller, Tobacco Control, Published Online First: 22 July 2025, doi: 10.1136/tc-2025-059527

“Keep it a secret”: leaked documents suggest Philip Morris International, and its Japanese affiliate, continue to exploit science for profit, S. Braznell, L. Laurence, I. Fitzpatrick, A.B. Gilmore, Nicotine and Tobacco Research, Published Online First: 27 June 2024, doi:10.1093/ntr/ntae101

Seeking to be seen as legitimate members of the scientific community? An analysis of British American Tobacco and Philip Morris International’s involvement in scientific events, B. K. Matthes, A. Fabbri, S. Dance, L. Laurence, K. Silver, A. B. Gilmore, Tobacco Control, 2023, doi: 10.1136/tc-2022-057809

The Science for Profit Model—How and why corporations influence science and the use of science in policy and practice, T. Legg, J. Hatchard and A.B. Gilmore, Plos One, 2021, 16(6), doi:10.1371/journal.pone.0253272

References

  1. P. Chaturvedi, A. Singh, C-Y. Chien, S. Warnakulasuriya, Tobacco related oral cancer, BMJ, 5 June 2019;365:l2142, doi: 10.1136/bmj.l2142
  2. S.L. Tomar, The Transnational Tobacco Industry and Oral Health, Community Dental Health, 30 May 2019, 36(2):163-168, doi:10.1922/CDH_SpecialIssueTomar06
  3. abcS. Braznell, L. Laurence, I. Fitzpatrick, A.B. Gilmore, “Keep it a secret”: leaked documents suggest Philip Morris International, and its Japanese affiliate, continue to exploit science for profitNicotine and Tobacco Research, Published Online First: 27 June 2024, doi:10.1093/ntr/ntae101
  4. T. Hirano, T. Hanioka, Philip Morris International advertisements target the oral health field in Japan, contrary to the latest World Dental Federation Policy Statement, Tobacco Control, 2024;33:279-280, doi: 10.1136/tc-2021-057191
  5. B. K. Matthes, A. Fabbri, S. Dance, et al Seeking to be seen as legitimate members of the scientific community? An analysis of British American Tobacco and Philip Morris International’s involvement in scientific eventsTobacco Control, 2023, doi: 10.1136/tc-2022-057809
  6. Collegio de Docenti Universitari Di Discipline Odontostomatologiche, 26th  Congresso Nazionale. 2019: Sponsor, conference programme, p.64, archived April 2022, accessed October 2024
  7. Sofia Dental Meeting, Programme: 2:15 – 13:00 Sponsored lecture by Phillip Morris, September 2018, accessed October 2024
  8. abPhilip Morris Products, Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome, 2017-2019, ClinicalTrials.gov ID: NCT03364751
  9. A. Dalrymple, T.C. Badrock, A. Terry et al /British American Tobacco, Assessment of enamel discoloration in vitro following exposure to cigarette smoke and emissions from novel vapor and tobacco heating products, American Journal of Dentistry, 2018 Oct;31(5):227-233, PMID: 30346667
  10. T. Kurachi, S. Chuman, T. Suzuki et al/Japan Tobacco Group, Effects of aerosols from heated tobacco products with flavors on the discoloration of bovine tooth enamelClinical and Experimental Dental Research, 2023, 9, 1070–1078, doi:10.1002/cre2.764
  11. J. Liu, J.S. Edmiston, J. Wang, Oral Health Effects Among Adults Switching from Cigarettes to on!® Nicotine Pouches Compared to Those Who Continue Smoking, Oral Health and Preventative Dentistry, 2025, 23: 189-201, doi:10.3290/j.ohpd.c_1925
  12. abcdeB.K. Matthes, L. Graen, K. Schaller, “Let us all work together for the larger public health good.” Philip Morris targeting German dental professionalsTobacco Control, Published Online First: 22 July 2025, doi: 10.1136/tc-2025-059527
  13. abcdefT. Hirano, T. Hanioka, Philip Morris International advertisements target the oral health field in Japan, contrary to the latest World Dental Federation Policy Statement, Tobacco Control, 2024;33:279-280, doi: 10.1136/tc-2021-057191
  14. I. Fitzpatrick, S. Dance, K. Silver et al, Tobacco industry messaging around harm: Narrative framing in PMI and BAT press releases and annual reports 2011 to 2021, Frontiers in Public Health, 18 October 2022, Sec. Public Health Policy, doi:10.3389/fpubh.2022.958354
  15. abSTOP, Today Japan, Tomorrow the World, Philip Morris Japan’s Leaked Marketing Blueprint for IQOS, February 2024, available from exposetobacco.org
  16. The Bureau of Investigative Journalism, Inside the Strategy Doc Philip Morris Never Meant You to See, 1 July 2024, accessed January 2025
  17. abcJ. Booth, Cigarette giant wants dentists to understand tobacco harm reduction, Dental Tribune (Europe edition), 8 September 2020, accessed September 2020
  18. abcD. Caruana, PMI: Dentists Should Learn About Harm Reduction, Vaping Post, 11 November 2020, accessed January 2025
  19. Philip Morris International, Risikoreduzierung für Raucher: Kartografie zeigt großen Informationswunsch bei deutschen Gesundheitsexperten, PM GMBH press release [in German], 20 May 2020, accessed September 2020
  20. F. Zanetti, A. Sewer, C. Mathis et al/Philip Morris International, Systems Toxicology Assessment of the Biological Impact of a Candidate Modified Risk Tobacco Product on Human Organotypic Oral Epithelial Cultures, Chem. Res. Toxicol. 2016, 29, 8, 1252–1269, doi:10.1021/acs.chemrestox.6b00174
  21. F. Zanetti, A. Sewer, E. Scotti et al/Philip Morris International, Assessment of the impact of aerosol from a potential modified risk tobacco product compared with cigarette smoke on human organotypic oral epithelial cultures under different exposure regimens, Food and Chemical Toxicology, Vol. 115, 2018, doi:10.1016/j.fct.2018.02.062
  22. X. Zhao, F. Zanetti, S. Majeed et al/ Philip Morris International,  Effects of cigarette smoking on color stability of dental resin composites, Am J Dent, 2017 Dec;30(6):316-322. PMID: 29251454
  23. F.Zanetti, X. Zhao, J. Pan et al/Philip Morris International, Effects of cigarette smoke and tobacco heating aerosol on color stability of dental enamel, dentin, and composite resin restorations, Quintessence International, 25 January 2019, doi: 10.3290/j.qi.a41601
  24. A. Haiduc, F. Zanetti, X. Zhao et al/Philip Morris International, Analysis of chemical deposits on tooth enamel exposed to total particulate matter from cigarette smoke and tobacco heating system 2.2 aerosol by novel GC–MS deconvolution procedures, Journal of Chromatography B, Volume 1152, 2020, 122228, doi: 10.1016/j.jchromb.2020.122228
  25. abPhilip Morris International, Tobacco Heating System (THS) aerosol stains teeth less than cigarette smoke, website, 25 June 2019, archived July 2022, accessed March 2025 at pmiscience.com
  26. X. Zhao, F. Zanetti, L. Wang et al, Effects of different discoloration challenges and whitening treatments on dental hard tissues and composite resin restorations, Journal of Dentistry, Volume 89, 2019, 103182, doi:10.1016/j.jdent.2019.103182
  27. X. Zhao, F. Zanetti, L. Wang et al, Effects of whitening toothpaste and bleaching treatment on resin composite discoloration caused by cigarette smoke and electronic vapor aerosol, Am. J. Dent., 2021 Apr;34(2):63-69, PMID: 33940661
  28. S. Pouly, W.T. Ng, M. Benzimra et al/Philip Morris International, Effect of Switching to the Tobacco Heating System Versus Continued Cigarette Smoking on Chronic Generalized Periodontitis Treatment Outcome: Protocol for a Randomized Controlled Multicenter Study, JMIR Res Protoc, 2021;10(1):e15350, doi: 10.2196/15350
  29. S. Pouly, W.T. Ng, N. Blanc, et al/ Philip Morris International, Effect of switching from cigarette smoking to the use of the tobacco heating system on periodontitis treatment outcome: Periodontal parameter results from a multicenter Japanese study, Front. Dent. Med, 22 July 2022, Sec. Periodontics, Volume 3 – 2022, doi:10.3389/fdmed.2022.915079
  30. S. Pouly, W.T. Ng, N. Blanc, et al/ Philip Morris International, Effect of switching from cigarette smoking to the use of the tobacco heating system on periodontitis treatment outcome: Periodontal parameter results from a multicenter Japanese study, Front. Dent. Med, 22 July 2022, Sec. Periodontics, Volume 3 – 2022, doi:10.3389/fdmed.2022.915079
  31. World Dental Federation/Fédération Dentaire Internationale, The Role of Oral Health Practitioners in Tobacco Cessation, 2021, policy statement. Available from fdiworlddental.org
  32. Philip Morris International, Funf Mythen rund um Schadensminderung beim Rauchen, Dental Aktuell, p.354-355, June 2024, accessed March 2025
  33. Philip Morris International, Schadensminderung beim Rauchen (Harm Reduction from Smoking), Spitta Dentalwelt, January 2025, accessed March 2025
  34. Philip Morris International, Vier Fragen zur Risikoreduzierung mittels E-Zigaretten und Tabakerhitzern (Four questions about risk reduction using e-cigarettes and tobacco heating devices), Dental Tribune, 12 May 2021, accessed March 2025
  35. Philip Morris International, Barrieren des Rauchstopps: Welche Rolle spielen Alternativen wie E-Zigarette und Tabakerhitzer? (Barriers to quitting smoking: What role do alternatives such as e-cigarettes and tobacco heaters play?), Spitta Akademie, webinar, 21 September 2023, website accessed
  36. Philip Morris International, Rauchende Patienten: Sind Alternativen zur Zigarette wie E-Zigarette und Tabakerhitzer eine Option der Risikoreduktion? (Smoking patients: Are alternatives to cigarettes such as e-cigarettes and tobacco heaters an option for risk reduction?), webinar, 8 December 2021, website archived November 2021, accessed March 2025
  37. Foundation for a Smoke-Free World/Global Action to End Smoking, Foundation For A Smoke-Free World Names Clifford Douglas CEO As Global Voice In Smoking Cessation Work, press release, 12 October 2023, modified 11 April 2024, accessed September 2025
  38. Knowledge Action Change, KAC Scholars 2018/2019, website, undated, archived October 2019, accessed March 2025
  39. Knowledge Action Change, KAC Scholars 2018/19: Examing [sic] the Effects of ‘Heat Not Burn’ Products, Compared to Tobacco, on Peridontal Disease, KAC website [page no longer available], undated, archived 12 November 2019, accessed September 2020
  40. M. Raescu, Effect of vaping or oral health in Romania, KAC website [page no longer available], undated, archived October 2019, accessed September 2020
  41. Global Forum on Nicotine, Scholarship 2019 – 2018 scholars and their projects: Dr Mihaela Raescu, GFN website, undated, archived 18 May 2020, accessed September 2020
  42. M. Raescu, The effect of switching from smoking to other alternative of non-combustible tobacco products on oral health, presentation at 6th Global Forum on Nicotine, undated, accessed September 2020
  43. M. Raescu, The effect of switching from smoking to other alternative of noncombustible tobacco products on oral health in Romania, Knowledge Action Change scholarship report, undated [no longer publicly available]
  44. M. Raescu, C.N. Cumpata, F.T. Dogaru et al, The Innovative Heath Not Burn (HNB) And Oral Health – A New Approach, Romanian Journal of Oral Rehabilitation, Vol. 13, No. 4 October-December 2021
  45. Global Action to End Smoking, ECLAT SRL, website, September 2019, updated March 2024, accessed March 2025
  46. CoEHAR, Smile Study: A smile to quit smoking, CoEHAR website, 27 October 2022, accessed July 2024
  47. G. Conte, S.A. Pacino, S. Urso et al, International Randomized Controlled Trial Evaluating Changes in Oral Health in Smokers after Switching to Combustion-Free Nicotine Delivery Systems: SMILE Study protocol, December 2024, medRxiv 2020.12.12.20240143, doi: https://doi.org/10.1101/2020.12.12.20240143 (preprint)
  48. Eclat Srl., Changes in Oral Health in Tobacco Cigarettes Smokers After Switching to Combustion-Free Nicotine Delivery Systems (SMILE), ClinicalTrials.gov, updated 21 February 2021, accessed February 2024
  49. G. Conte, S.A. Pacino, S. Urso et al, Repeatability of dental shade by digital spectrophotometry in current, former, and never smokersOdontology, 110, 605–618 (2022), doi:10.1007/s10266-022-00692-x
  50. G. Conte, A. Amaliya, S. Gupta S et al, Repeatability of dental plaque quantitation by light induced fluorescence technology in current, former, and never smokers, BMC Oral Health, 2023 Jul 13;23(1):480, doi: 10.1186/s12903-023-03154-0
  51. abS. Gupta, V. Sahni, R. Emma et al, E-cigarettes and heated tobacco products impact on dental color parameters, Heliyon, Volume 10, Issue 3, 2024, e24084, doi:10.1016/j.heliyon.2024.e24084
  52. G. Conte, S.A. Pacino, S. Urso et al, Changes in Oral Health and Dental Esthetic in Smokers Switching to Combustion-Free Nicotine Alternatives: Protocol for a Multicenter and Prospective Randomized Controlled Trial, JMIR Res Protoc, 2024;13:e53222, doi: 10.2196/53222
  53. abcG.R. Maria La Rosa, A. Di Stefano, D. Gangi et al, Dental plaque quantitation by light induced fluorescence technology in exclusive Electronic Nicotine Delivery Systems (ENDS) users, Journal of Dentistry, Volume 147, 2024, 105223, doi:10.1016/j.jdent.2024.105223
  54. World Health Organisation, Heated tobacco products: information sheet (2nd edition), July 2020, available from who.int
  55. World Health Organisation, Conference of the Parties to the WHO Framework Convention on Tobacco Control, DECISION FCTC/COP8(22) Novel and emerging tobacco products,  Geneva, Switzerland, 6 October 2018. Available from who.int
  56. Secretariat of the WHO FCTC, Information Note on classification of novel and emerging tobacco products, 15 March 2019. Available from who.int
  57. abCoEHAR, New collaborative projects between Padjadjaran University and the University of Catania for studies on harm reduction in Indonesia, CoEHAR Press Release, 4 July 2024, accessed July 2024